Clinical Trial Update: Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting dose optimization of sitagliptin and duloxetine in patients with diabetic cirrhosis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Liver Cirrhosis

Drugs mentioned

• Duloxetine (DULOXETINE)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Liver Cirrhosis With Diabetes | Phase 4 | Status: COMPLETED